Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 23 of 23 entries
View as:

Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)

Phase: N/A Priority: Normal
NCT ID: NCT01741532 Org: User:
Start: 12/13/12 End: 01/11/17 Due: 01/11/18

An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01770652 Org: User:
Start: 01/31/13 End: 08/31/13 Due: 08/31/14

Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration

Phase: N/A Priority: Normal
NCT ID: NCT02174848 Org: User:
Start: 06/30/14 End: 03/16/18 Due: 03/16/19

Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT01835496 Org: User:
Start: 05/31/13 End: 04/30/14 Due: 04/30/15

Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01483924 Org: User:
Start: 11/30/11 End: 10/31/13 Due: 10/31/14

Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01860703 Org: User:
Start: 11/30/12 End: 07/31/13 Due: 07/31/14

Comparison of Deferiprone Extended Release Tablets and Ferriprox Immediate Release Tablets in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02465489 Org: User:
Start: 06/30/15 End: 08/31/15 Due: 08/31/16

Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT00529152 Org: User:
Start: 08/31/07 End: 07/31/08 Due: 07/31/09

Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00387101 Org: User:
Start: 02/28/06 End: 04/30/08 Due: 04/30/09

A Blinded, Placebo-Controlled Study of the Safety and Pharmacokinetics of Single Doses of Intravenous Deferiprone in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01989455 Org: User:
Start: 11/30/13 End: 03/31/14 Due: 03/31/15

Efficacy Study in Removing Excess Iron From the Heart

Phase: N/A Priority: Normal
NCT ID: NCT00105495 Org: User:
Start: 12/31/02 End: 10/31/04 Due: 10/31/05

Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias

Phase: N/A Priority: Normal
NCT ID: NCT02443545 Org: User:
Start: 05/21/15 End: 08/21/19 Due: 08/21/20

Study of Parkinson's Early Stage With Deferiprone

Phase: N/A Priority: Normal
NCT ID: NCT02728843 Org: User:
Start: 10/12/16 End: 09/04/19 Due: 09/04/20

Pilot Study of the Pharmacokinetic Profile of Deferiprone Sustained-Release Formulation in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02189941 Org: User:
Start: 05/31/14 End: 06/30/14 Due: 06/30/15

A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia

Phase: N/A Priority: Normal
NCT ID: NCT00530127 Org: User:
Start: 04/30/08 End: 07/31/09 Due: 07/31/10

Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias

Phase: N/A Priority: Normal
NCT ID: NCT02041299 Org: User:
Start: 04/17/14 End: 06/18/19 Due: 06/18/20

An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01767103 Org: User:
Start: 01/31/13 End: 04/30/14 Due: 04/30/15

Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02456558 Org: User:
Start: 06/30/15 End: 05/31/16 Due: 05/31/17

Active Drug Surveillance Program of Ferriprox Use

Phase: N/A Priority: Normal
NCT ID: NCT01838291 Org: User:
Start: 06/30/10 End: 04/30/13 Due: 04/30/14

Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02191657 Org: User:
Start: 11/30/06 End: 04/30/10 Due: 04/30/11

A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia

Phase: N/A Priority: Normal
NCT ID: NCT00897221 Org: User:
Start: 06/30/09 End: 03/31/11 Due: 03/31/12

Safety and Acceptability of Deferiprone Delayed Release Tablets in Patients With Systemic Iron Overload

Phase: N/A Priority: Normal
NCT ID: NCT03802916 Org: User:
Start: 03/06/19 End: 12/19/19 Due: 12/19/20

Comparison of Deferiprone Delayed Release Tablets and Deferiprone Oral Solution in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02442310 Org: User:
Start: 05/31/15 End: 07/31/15 Due: 07/31/16